Long term Buy on UBER cmp $86.34Uber has given a clear breakout on the monthly charts above $82.14. Considering this move i have a target of $140 in coming months.
CMP : $82.14
Expected: $140-155
Stocktrends
Buy indication for long term investors MicroStrategy "MSTR"The stock has given channel breakout on monthly charts hence i consider this as a very strong buy signal. Todays move above $201 with high volumes indicate strong hand took some stocks home. There is definitely some positive news coming up. Any consolidation on channel is a buy on dips.
Alerts for long term investors
#USA #canada #NASDAQ #NEWYORK #software #MSTR
Current price $212.59
Expect - $300,350
Stop loss $150
Meta stock for Short in Strong Up Trend.meta stock is currently in strong up trend but in shorter duration is will likely to consolidate and show down trend towards 520-510 . weekly duration we can see little downside in meta stock.
Dow Jones March 2020 $DJI. Touches Trend Line for 3rd time. After a week of strong selling the Dow Jones has touched the 12 year trend line for the 3rd time. Had not had a touch for 4 years. In this Channel is a good sign. At some point I would expect a third touch of the upper trend line. No need to panic sell everything in my opinion. Just think, a vaccine is being created for Covid19, do you really think that billionaires aren't buying at these levels.
Another Big Move For TRIL But Can It Finally Break Up & Out?TRIL did a great job of executing over the past few months in my opinion. It was enough to not only fill the previous gap but also get back to levels it was at prior to the big sell-off. My fear, however, isn't fundamental but more technical as there may be strong resistance at these levels with some "bag holders" seeing it as a potential opportunity to break even? IDK but just speculating here. Either way, it's great to see this is still on the move .
"On Tuesday, the company announced positive interim data on TTI 621. Soon enough the trading volumes on the stock rose significantly. “The program continues to demonstrate clear single agent activity across a range of hematologic malignancies, as well as a strong tolerability profile. We believe that TTI-621, even at these low initial doses, is the only anti-CD47 agent that has shown meaningful single agent activity, including complete responses,” said Dr. Jan Skvarka, President and Chief Executive Officer of Trillium."
SOURCE: 5 Penny Stocks To Watch Before Next Week; 1 Up 720 % Since December
